Journal
EINSTEIN-SAO PAULO
Volume 20, Issue -, Pages -Publisher
INST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEIN
DOI: 10.31744/einstein_journal/2022AO0104
Keywords
Meningioma; Receptors, somatostatin; Positron-emission tomography; Radiotherapy
Categories
Ask authors/readers for more resources
No significant difference in somatostatin analog uptake was found between meningiomas treated with radiation therapy and those that had not been treated.
Objective: To evaluate whether there is a significant difference in somatostatin analog uptake in meningiomas treated or not with radiation therapy. Methods: A cross-sectional study was performed comparing measurements of somatostatin analog (Ga-68-DOTATATE) uptake in two independent groups of ten patients each - one consisting of patients with meningiomas previously treated with radiation therapy and another comprising patients who had never been submitted to radiation therapy. All patients underwent PET/CT and MRI scans in an interval shorter than 24 hours between exams. Results: A total of 32 meningiomas from 20 patients were analyzed, all presenting significant somatostatin analog uptake in different degrees. The uptake levels of somatostatin analog were similar between the lesions treated or not with radiation therapy, and the mean values of SUVmax were 27.62 and 24.82, respectively (p = 0.722). For SUVmean, the values were 16.20 and 14.82, respectively (p= 0.822). Conclusion: Comparative analysis between the groups showed no significant differences in degree of somatostatin analog uptake in successfully irradiated and non-irradiated meningiomas.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available